These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 37108374

  • 21. Phenotypic profiling of pancreatic ductal adenocarcinoma plasma-derived small extracellular vesicles for cancer diagnosis and cancer stage prediction: a proof-of-concept study.
    Zhang W, Wang L, Li D, Campbell DH, Walsh BJ, Packer NH, Dong Q, Wang E, Wang Y.
    Anal Methods; 2022 Jun 16; 14(23):2255-2265. PubMed ID: 35612592
    [Abstract] [Full Text] [Related]

  • 22. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients.
    Sun B, Liu X, Gao Y, Li L, Dong Z.
    Br J Biomed Sci; 2016 Oct 16; 73(4):152-157. PubMed ID: 27922430
    [Abstract] [Full Text] [Related]

  • 23. MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions.
    du Rieu MC, Torrisani J, Selves J, Al Saati T, Souque A, Dufresne M, Tsongalis GJ, Suriawinata AA, Carrère N, Buscail L, Cordelier P.
    Clin Chem; 2010 Apr 16; 56(4):603-12. PubMed ID: 20093556
    [Abstract] [Full Text] [Related]

  • 24. Liquid Biopsy for Pancreatic Cancer by Serum Extracellular Vesicle-Encapsulated Long Noncoding RNA HEVEPA.
    Takahashi K, Inuzuka T, Shimizu Y, Sawamoto K, Taniue K, Ono Y, Asai F, Koyama K, Sato H, Kawabata H, Iwamoto H, Yamakita K, Kitano Y, Teramoto T, Fujiya M, Fujii S, Mizukami Y, Okumura T.
    Pancreas; 2024 May 01; 53(5):e395-e404. PubMed ID: 38416857
    [Abstract] [Full Text] [Related]

  • 25. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
    Uysal-Onganer P, D'Alessio S, Mortoglou M, Kraev I, Lange S.
    Int J Mol Sci; 2021 Jan 30; 22(3):. PubMed ID: 33573274
    [Abstract] [Full Text] [Related]

  • 26. A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile.
    Cote GA, Gore AJ, McElyea SD, Heathers LE, Xu H, Sherman S, Korc M.
    Am J Gastroenterol; 2014 Dec 30; 109(12):1942-52. PubMed ID: 25350767
    [Abstract] [Full Text] [Related]

  • 27. Analysis of Blood Plasma MicroRNAs to Enable Identification of Patients with Pancreatic Ductal Adenocarcinoma Who Will Benefit from Surgical Resection.
    Gablo N. A, Procházka V, Hlavsa J, Kiss I, Srovnal J, Kala Z, Slabý O.
    Klin Onkol; 2019 Dec 30; 32(Suppl 1):174-176. PubMed ID: 31064193
    [Abstract] [Full Text] [Related]

  • 28. MicroRNA-153 is a prognostic marker and inhibits cell migration and invasion by targeting SNAI1 in human pancreatic ductal adenocarcinoma.
    Bai Z, Sun J, Wang X, Wang H, Pei H, Zhang Z.
    Oncol Rep; 2015 Aug 30; 34(2):595-602. PubMed ID: 26062664
    [Abstract] [Full Text] [Related]

  • 29. Size and Concentration of Extracellular Vesicles in Pancreatic Juice From Patients With Pancreatic Ductal Adenocarcinoma.
    Nesteruk K, Levink IJM, Dits NFJ, Cahen DL, Peppelenbosch MP, Bruno MJ, Fuhler GM.
    Clin Transl Gastroenterol; 2022 Feb 18; 13(3):e00465. PubMed ID: 35363220
    [Abstract] [Full Text] [Related]

  • 30. Extracellular vesicles from pancreatic ductal adenocarcinoma endoscopic ultrasound-fine needle aspiration samples contain a protein barcode.
    Inoue H, Eguchi A, Kobayashi Y, Usugi E, Yamada R, Tsuboi J, Akuta T, Horiki N, Iwasa M, Takei Y.
    J Hepatobiliary Pancreat Sci; 2022 Mar 18; 29(3):394-403. PubMed ID: 34555251
    [Abstract] [Full Text] [Related]

  • 31. Integrin α6A (ITGA6A)-type Splice Variant in Extracellular Vesicles Has a Potential as a Novel Marker of the Early Recurrence of Pancreatic Cancer.
    Asada T, Nakahata S, Fauzi YR, Ichikawa T, Inoue K, Shibata N, Fujii Y, Imamura N, Hiyoshi M, Nanashima A, Morishita K.
    Anticancer Res; 2022 Apr 18; 42(4):1763-1775. PubMed ID: 35346995
    [Abstract] [Full Text] [Related]

  • 32. Panel of serum miRNAs as potential non-invasive biomarkers for pancreatic ductal adenocarcinoma.
    Khan IA, Rashid S, Singh N, Rashid S, Singh V, Gunjan D, Das P, Dash NR, Pandey RM, Chauhan SS, Gupta S, Saraya A.
    Sci Rep; 2021 Feb 02; 11(1):2824. PubMed ID: 33531550
    [Abstract] [Full Text] [Related]

  • 33. The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma.
    Michael Traeger M, Rehkaemper J, Ullerich H, Steinestel K, Wardelmann E, Senninger N, Abdallah Dhayat S.
    J Cancer Res Clin Oncol; 2018 Dec 02; 144(12):2419-2431. PubMed ID: 30244390
    [Abstract] [Full Text] [Related]

  • 34. An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma.
    Makler A, Narayanan R, Asghar W.
    Biosensors (Basel); 2022 Oct 06; 12(10):. PubMed ID: 36290970
    [Abstract] [Full Text] [Related]

  • 35. Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Resection.
    Karasek P, Gablo N, Hlavsa J, Kiss I, Vychytilova-Faltejskova P, Hermanova M, Kala Z, Slaby O, Prochazka V.
    Cancer Genomics Proteomics; 2018 Oct 06; 15(4):321-327. PubMed ID: 29976637
    [Abstract] [Full Text] [Related]

  • 36. Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma.
    Yu S, Li Y, Liao Z, Wang Z, Wang Z, Li Y, Qian L, Zhao J, Zong H, Kang B, Zou WB, Chen K, He X, Meng Z, Chen Z, Huang S, Wang P.
    Gut; 2020 Mar 06; 69(3):540-550. PubMed ID: 31562239
    [Abstract] [Full Text] [Related]

  • 37. Emerging Horizons in the Diagnosis of Pancreatic Cancer: The Role of Circulating microRNAs as Early Detection Biomarkers for Pancreatic Ductal Adenocarcinoma.
    Reyaz I, Khan B, James N, Azhar H, Rehman A, Younas MW, Rashid H, Al-Shaikhly FF, Almomani MM, I Kh Almadhoun MK, Abdullah Yahya N, Bokhari SFH, Shehzad A.
    Cureus; 2024 Jan 06; 16(1):e53023. PubMed ID: 38410292
    [Abstract] [Full Text] [Related]

  • 38. Biomarkers for early detection of pancreatic cancer - miRNAs as a potential diagnostic and therapeutic tool?
    Tarasiuk A, Mackiewicz T, Małecka-Panas E, Fichna J.
    Cancer Biol Ther; 2021 Jun 03; 22(5-6):347-356. PubMed ID: 34224317
    [Abstract] [Full Text] [Related]

  • 39. Detection of mitochondrial DNA mutations in circulating mitochondria-originated extracellular vesicles for potential diagnostic applications in pancreatic adenocarcinoma.
    Vikramdeo KS, Anand S, Khan MA, Khushman M, Heslin MJ, Singh S, Singh AP, Dasgupta S.
    Sci Rep; 2022 Nov 02; 12(1):18455. PubMed ID: 36323735
    [Abstract] [Full Text] [Related]

  • 40. Circulating miRNAs as Noninvasive Biomarkers for PDAC Diagnosis and Prognosis in Mexico.
    Álvarez-Hilario LG, Salmerón-Bárcenas EG, Ávila-López PA, Hernández-Montes G, Aréchaga-Ocampo E, Herrera-Goepfert R, Albores-Saavedra J, Manzano-Robleda MDC, Saldívar-Cerón HI, Martínez-Frías SP, Thompson-Bonilla MDR, Vargas M, Hernández-Rivas R.
    Int J Mol Sci; 2023 Oct 14; 24(20):. PubMed ID: 37894871
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.